 | Cerevel Therapeutics Holdings, | |||
| NCM : CERE || Location: United States | ||||
$41.9-0.09 (-0.21%) |
0.63 M | 41.87 - 42.06 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 7.924 M |
| March 28, 2024 | 9.623 M |
| March 15, 2024 | 6.963 M |
| Feb. 29, 2024 | 7.099 M |
| Feb. 15, 2024 | 6.781 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.61 | -0.76 | -25.25% |
| 09/30/2023 | -0.64 | -0.61 | 5.41% |
| 06/30/2023 | -0.66 | -0.63 | 4.76% |
| 03/31/2023 | -0.69 | -0.67 | 2.59% |
| 12/31/2022 | -0.65 | -0.59 | 9.76% |
CERE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 181.576M | Shares Float | 77.226M |
| Short Float | 7.924M | Market Cap | 7608.03M |
| Institution ownership | 86.23% | Insider ownership | 15.325% |
| Earnings Date | 05/01/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.67 | Forward EPS | -2.81 |